BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 24, 2013
View Archived Issues
PDL BioPharma acquires royalty rights and milestones for type 2 diabetes products from Depomed
Read More
Researchers at Bristol-Myers Squibb present novel inhibitors of endothelial lipase
Read More
InnoCore and Allergan expand collaboration to develop new medicines for ophthalmic diseases
Read More
Boehringer Ingelheim describes new GPR40 receptor agonists
Read More
Isis Pharmaceuticals patents novel antisense oligonucleotides
Read More
Anacor receives award from Department of Defense for new classes of systemic antibiotics
Read More
Qiagen and Clovis partner to develop companion diagnostic for lung cancer candidate
Read More
MedMira receives further U.S. Army funding to develop tests for transfusion transmitted diseases
Read More
Merck & Co.'s combination regimen for chronic HCV obtains FDA breakthrough therapy designation
Read More
Russian company completes initial clinical trial steps for ABP-560
Read More
Taiho presents TAS-121, a potent and selective EGFR inhibitor
Read More
Gene therapy company Spark Therapeutics spun out of The Children's Hospital of Philadelphia
Read More
Antisense oligonucleotide ISIS-560131 targets the androgen receptor and reduces tumor growth in vivo
Read More
ERP29, IKBKAP gene polymorphisms associated with breast cancer risk and clinical features
Read More
Pharmacokinetics and pharmacodynamics determined for CW-002 in healthy volunteers
Read More
Mouse model created for genetic susceptibility to both dementia and Parkinson's disease
Read More
Daiichi Sankyo discloses new SGLT1/SGLT2 inhibitors
Read More
Merck & Co. and ElexoPharm prepare novel CYP11B2 inhibitors
Read More
New MCH1 receptor antagonists reported by GlaxoSmithKline
Read More
Sucampo and Takeda begin pivotal trial of lubiprostone liquid formulation
Read More
Roche recaps progress of third quarter 2013
Read More
ViiV Healthcare submits NDA for single-tablet HIV regimen
Read More
Enrollment complete in phase III trial of ZS-9 for treatment of hyperkalemia
Read More
DBV Technologies and INSERM form collaboration to develop Viaskin for refractory hemophilia A
Read More
Epirus and Orygen Biotecnologia sign collaboration agreement for biotechnology products in Brazil
Read More